Interní Med. 2009; 11(5): 245-249

Tiotropium in COPD - the early therapy, the better results

MUDr. Vratislav Sedlák, MUDr. Vladimír Koblížek
Plicní klinika, Ušní, nosní a krční klinika, Neurologická klinika, Psychiatrická klinika, Hradec Králové

COPD is chronic progresive disease associated with high morbidity and mortality and increasing prevalence. Management of COPD

is based on prevention and treatment of exacerbations, decreasing of mortality, aleviating of symptoms and influence of long-term

prognosis. The most important part of this strategy is to identify patients with early stages, where is a potential for slowing the disease

progression. This review summarizes role of long-acting muscarinic antagonist tiotropium in current COPD management and especially

its impact on declination of lung function.

Keywords: COPD, anticholinergics, tiotropium.

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sedlák V, Koblížek V. Tiotropium in COPD - the early therapy, the better results. Interní Med. 2009;11(5):245-249.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ashutosh K, Lang H. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol. Ann Allergy 1984; 53: 401-406.
    2. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. New Engl J Med 1984; 311: 421-425. Go to original source... Go to PubMed...
    3. Braun SR, McKenzie WN, Copeland C, et al. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 1989; 149: 544-547. Go to original source...
    4. Jenkins CR, Chow CM, Fisher BL, Marlin GE. Ipratropium bromide and fenoterol by aerosolized solution. Br J Clin Pharmacol 1982; 14: 113-115. Go to original source... Go to PubMed...
    5. van Noord JA, de Munck DR, Bantje TA, et al. Long-term treatment of COPD with salmeterol and the additive effect of ipratropium. Eur Respir J 2000; 15: 878-885. Go to original source... Go to PubMed...
    6. Vincken W, van Noord JA, Greefhorst APM, et al. Improved health outcomes in patients with COPD during 1 years treatment with tiotropium. Eur. Respir J 2002; 19: 209-216. Go to original source... Go to PubMed...
    7. Oestenbrink JB, Rutten-van Molken MPMH, Al MJ, et al. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Eur Respir J 2004; 23: 241-249. Go to original source... Go to PubMed...
    8. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med; 359: 1543-1554. Go to original source... Go to PubMed...
    9. Briggs DD Jr, Covelli H, Lapidus R, Bhattycharya S, Kesten S, Cassino C, Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther 2005; 18 (6): 397-404. Go to original source... Go to PubMed...
    10. Donohue JF, van Noord JA, Bateman ED, Langkey SJ, Lee A, et al. A 6-month, placebo controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55. Go to original source... Go to PubMed...
    11. Barr RG, Bourbeau J, Camargo CA, Ram FSF. Tiotropium for stable chronic obstructive pulmonary disease: a meta analysis. Thorax 2006; 61: 854-862. Go to original source... Go to PubMed...
    12. O'Donnel DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea, and excercise tolerance in COPD. Eur Respir J 2004; 23: 832-840. Go to original source... Go to PubMed...
    13. Aaron SD, Vandemheen KL, Fergusson D. Tiotropium in combination with placebo, salmeterol or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Ann Intern Med 2007; 23: 146: 545-555. Go to original source... Go to PubMed...
    14. Vincken W. Tiotropium bromide. Pharma iv. Clinical publishing. Oxford.
    15. Rabe KF, Timmer W, Sagriotis A, Viel K. Comparison of combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD. Eur Respir J 2005; 26 (Suppl 49) 14 s.
    16. Drummond MB, Dasenbrook EC, Pitz W, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease. A systematic review and Meta analysis. JAMA 2008; 300: 2407-2416. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.